Cart
sales@molnova.com
Marmesin b
CAS No. 13710-70-8
Marmesin b( —— )
Catalog No. M31316 CAS No. 13710-70-8
Marmesin is a novel angiogenesis inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 299 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMarmesin b
-
NoteResearch use only, not for human use.
-
Brief DescriptionMarmesin is a novel angiogenesis inhibitor.
-
DescriptionMarmesin is a novel angiogenesis inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13710-70-8
-
Formula Weight246.3
-
Molecular FormulaC14H14O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Phyllanthusiin C
Phyllanthusiin C is a natural product of Terminalia, Combretaceae. Phyllanthusiin C can be used as a reference standard.
-
Methyl2-(methylamino...
Methyl2-(methylamino)benzoate is anatural product.
-
Luxdegalutamide
Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.
